Interleukin-18 in pediatric rheumatic diseases.
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Rheumatology"
DOI: 10.1097/bor.0000000000000634
Abstract: PURPOSE OF REVIEW IL-18 is a pleiotropic cytokine involved in the regulation of innate and adaptive immune responses. IL-18 pro-inflammatory activities are finely regulated in vivo by the inhibitory effects of the soluble IL-18-binding protein… read more here.
Keywords: rheumatic diseases; pediatric rheumatic; interleukin pediatric; rheumatology ... See more keywords
THU0509 IMPACT OF PEDIATRIC RHEUMATIC DISEASES ON MEXICAN CAREGIVERS.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.6436
Abstract: Pediatric rheumatic diseases (PRD) have an important impact on different aspects of the patients’ and caregivers’ life, such as physical, emotional, economic, and social. Some studies have shown that parents of patients with PRD have… read more here.
Keywords: diagnosis; pediatric rheumatic; thu0509 impact; impact ... See more keywords
The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.820586
Abstract: JAK-inhibitors are small molecules blocking the JAK-STAT pathway that have proven effective in the treatment of different immune-mediated diseases in adults and juvenile idiopathic arthritis (JIA). Aim of Study To evaluate the safety and efficacy… read more here.
Keywords: rheumatic diseases; efficacy tofacitinib; pediatric rheumatic; safety efficacy ... See more keywords